"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Sun Pharmaceutical Industries Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Dilip S Shanghvi
Home : Sun Pharma	Book Value: 93.2373503
BSE Code : 524715	Market Cap: 436666.97
NSE Code : SUNPHARMA	P / E : 145.48

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Type	4Qtr	3Qtr	2Qtr	1Qtr
Net Sales	4887.27	5651.21	4511.27	5559.27
Other Income	62.93	179.90	72.79	103.71
Total Income	4986.81	5867.67	4620.90	5698.59
Total Expenditure	3594.91	4187.87	3364.52	3972.99
Operating Profit	1391.90	1679.80	1256.38	1725.60
Interest	216.92	244.17	248.33	238.42
Gross Profit	1174.98	1435.63	1008.05	1487.18
Depreciation	325.97	338.53	336.30	310.92
Tax	240.31	391.66	107.53	431.20
Deferred Tax	0.00	0.00	0.00	0.00
Reported Profit After Tax	608.70	705.44	564.22	745.06

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView